This is the fifth and final article in a five-part series examining sexual pain and the many systems that contribute to it.

Over the past four weeks, we have explored the neurobiology of pain, the complexities of vulvodynia, the protective reflexes of vaginismus, and the often-overlooked role of pelvic floor dysfunction. Along the way, a common theme has emerged: sexual pain is rarely caused by a single structure, diagnosis, or event. More often, it represents the interaction of multiple physiologic systems operating simultaneously.

This final article focuses on treatment. Not a single treatment, but the broader philosophy that guides effective care. Because the question is not simply how to treat sexual pain. The question is how to identify the specific mechanisms creating pain in the first place.

Why Treatment Begins with Diagnosis

One of the biggest misconceptions about sexual pain is that there must be a single treatment capable of fixing it. Patients often arrive hoping for a cream, a pill, an injection, or a procedure that will make the pain disappear. Unfortunately, sexual pain is rarely that simple.

Firstly, it is singularly important to remember that pain is a symptom, not a diagnosis. A patient with hormonal vestibulodynia, pelvic floor dysfunction, or genitourinary syndrome of menopause may all describe the same complaint: pain with sex. Yet the physiology behind that pain, and therefore the appropriate treatment, may be entirely different.

This distinction matters because treatments ONLY work when they target the mechanism responsible for the pain, i.e., vaginal estrogen will not cure pelvic floor spasms, physical therapy will not reverse untreated lichen sclerosus, and so on. The best treatment for the wrong diagnosis is still the wrong treatment.

Yet sexual pain treatment is often portrayed as surprisingly simple: use more lubricant, relax, have a glass of wine, maybe try a hormone cream. For patients who have spent years struggling with pain, those recommendations can feel not only inadequate, but also insulting.

The reality is that modern sexual medicine has developed a remarkably broad treatment toolkit. As such, the challenge is not that treatments do not exist. Instead, the challenge is knowing which treatment belongs to which diagnosis. In the remainder of this article, we’ll explore how specialists approach sexual pain by focusing on four major targets of therapy: tissue, nerves, muscles, and anatomy.

Read more

This is the fourth article in a five-part series examining sexual pain and the conditions that commonly contribute to painful intimacy.

Previous articles explored vulvodynia and vaginismus, two conditions that frequently overlap with another often-overlooked contributor: pelvic floor dysfunction. While patients may assume their symptoms originate from the vulva or vagina alone, the muscles supporting the pelvis frequently play a central role in both the development and persistence of sexual pain.

This article examines pelvic floor dysfunction, how it develops, why it is commonly missed, and the ways in which muscular tension can influence everything from intercourse to urination, bowel function, posture, and chronic pain.

The Muscles You Never Think About

The pelvic floor is one of the least appreciated muscle groups in the human body. Most people can identify their biceps, quadriceps, or abdominal muscles, yet few can describe the muscles that support the bladder, rectum, reproductive organs, and core. Despite this lack of awareness, the pelvic floor works continuously throughout the day, helping coordinate everything from urination and defecation, to posture, movement, and sexual activity.

Under ideal circumstances, the pelvic floor behaves much like any other muscle group. It contracts when support is needed and relaxes when appropriate. Problems arise, therefore, when that balance is lost. Some individuals develop weakness and poor support, while others develop excessive tension, guarding, and chronic spasm. It is this latter group that is particularly relevant to sexual pain.

One useful analogy is to imagine walking around with your shoulders shrugged toward your ears all day long. Initially, you might notice mild tension. After weeks or months, however, pain, stiffness, headaches, and restricted movement would likely develop. The same principle applies to the pelvic floor. Muscles that remain chronically contracted eventually become painful, irritable, and dysfunctional.

Unfortunately, because these muscles are hidden from view, patients often have no idea they are tightening them. The resulting symptoms may be attributed to infections, gynecologic disease, aging, or stress, while the underlying muscular contribution remains undiagnosed.

How Pelvic Floor Dysfunction Develops

One of the most challenging aspects of pelvic floor dysfunction is that patients rarely identify a single causative event. Unlike a broken bone or surgical incision, there is often no obvious beginning. Instead, dysfunction typically develops gradually through the accumulation of multiple influences over time.

Pain, understandably, is one of the most common contributors to pelvic floor dysfunction. As discussed in previous articles, painful stimuli trigger protective muscular guarding. When this guarding becomes repetitive, the pelvic floor may remain partially contracted even after the original pain source has resolved. Over time, the nervous system begins treating this tension as the new normal.

Trauma, childbirth, pelvic surgery, athletic injury, even chronic constipation, and urinary dysfunction have all been associated with contributing to pelvic floor dysfunction. Psychological stress may also play a role, as many individuals unconsciously hold tension in the jaw, shoulders, or neck. Others (such as yours truly) hold it in the pelvic floor. The body does not necessarily distinguish between emotional and physical stress when generating muscular tension.

The result is a self-reinforcing cycle. Tight muscles generate pain. Pain triggers further guarding. Guarding creates additional tension. Eventually the patient may develop symptoms despite having no ongoing tissue injury whatsoever.

What Pelvic Floor Dysfunction Looks Like for Patients

One reason pelvic floor dysfunction is frequently missed is that its symptoms appear unrelated on the surface. Patients may present complaining of painful intercourse, may also have urinary urgency, while those with constipation may also present with difficulty sitting, or a vague sense of heaviness within the pelvis. Few realize these seemingly separate complaints may originate from the same muscular system.

In the context of sexual medicine, pain during penetration is one of the most common presentations. Patients often describe a dull, aching, stretching, or pressure-like sensation rather than the burning pain commonly associated with vulvodynia. Deep penetration may reproduce discomfort when contracted muscles are compressed during intercourse.

Many patients also report that certain positions are more tolerable than others. Others describe difficulty relaxing during intimacy or a sensation that their pelvis feels “tight” or “locked.” Some notice that their symptoms worsen during periods of stress, fatigue, or emotional distress.

Perhaps most tellingly, pelvic floor dysfunction rarely limits itself to sexual activity alone. The presence of some of the above-named symptoms often provide valuable clues that the problem extends beyond the reproductive organs themselves.

Diagnosing the Problem

Diagnosing pelvic floor dysfunction requires looking beyond traditional gynecologic pathology. Unfortunately, many patients will undergo extensive evaluations for infection, hormonal disorders, or even other conditions such as endometriosis before anyone assesses the pelvic floor itself. Yet in many cases, the answer is literally sitting beneath the surface.

In this case, a physical examination is essential. Assessment begins with observation of posture, gait, breathing patterns, and pelvic mechanics. The pelvic floor muscles can then be evaluated through targeted examination, allowing the clinician to identify areas of tenderness, spasm, weakness, or poor coordination.

One of the most validating moments for patients often occurs when their familiar pain is reproduced during examination. For years they may have been told nothing is wrong because imaging studies were normal. Suddenly, a specific muscle is identified that recreates exactly the discomfort they experience during intercourse. The pain becomes tangible and explainable.

At Haven Center, evaluation of the pelvic floor is a routine component of sexual pain assessment. It is not uncommon to discover that what initially appeared to be vulvodynia, vaginismus, bladder pain, or dyspareunia also involves a significant muscular component. Identifying that component often changes the treatment plan dramatically.

So, How Do We Restore Function?

The encouraging aspect of pelvic floor dysfunction is that it is often highly treatable once recognized. Unlike many chronic pain conditions, patients frequently experience meaningful improvement when muscular dysfunction is addressed directly.

As with many other aspects of sexual pain, pelvic floor physical therapy remains a cornerstone of treatment. Through a variety of modalities, including manual therapy, biofeedback, stretching, and neuromuscular reeducation, patients learn to recognize and release chronic tension patterns that may have existed for years. For many, simply becoming aware of their pelvic floor is the first step toward recovery.

Additional therapies may include muscle relaxants, lifestyle modification, counseling, and management of contributing bowel or bladder conditions. In selected patients with severe muscular spasm, chemodenervation with onabotulinumtoxinA (Botox) may provide significant benefit by interrupting long-standing guarding cycles.

At Haven Center, pelvic floor dysfunction is one of the most frequently encountered contributors to sexual pain. What makes the condition particularly fascinating is that it often exists at the intersection of neurology, musculoskeletal medicine, psychology, and sexual health. Successful treatment therefore requires more than simply relaxing a muscle, it requires helping the nervous system abandon a protective pattern it no longer needs.

In the final article of this series, we will bring these concepts together and examine treatment strategies for sexual pain more broadly. By this point, a common theme should be emerging: pain is rarely the result of a single structure or diagnosis. More often, it is the product of multiple interconnected systems that must be understood before they can be effectively treated.

© 2026 Corey R. Babb, DO, FACOOG, IF, MSCP. All rights reserved.

Share Dr. Corey Babb

This is the third article in a five-part series examining sexual pain and the systems that shape painful intimacy.

In the previous article, we looked at vulvodynia through the lens of chronic pain and nervous system sensitization. In many ways, vaginismus overlaps with many of those same processes. That said, it differs in one critically important concept: the body itself becomes actively protective. Instead of pain occurring solely from irritated tissue, penetration may become physically resisted through involuntary muscular contraction and anticipatory guarding.

This article focuses on vaginismus: what it is, why it develops, how the brain and pelvic floor reinforce one another over time, and why treatment requires far more than simply “trying to relax.”

What is Vaginismus?

Few conditions in sexual medicine are as misunderstood as vaginismus. Patients are often told the problem is psychological, anxiety-based, or simply the result of being “too tense.” While emotional and psychologic factors absolutely influence the condition, this framing dramatically oversimplifies what is ultimately a very real physiologic response involving reflexive muscular guarding.

Historically, vaginismus was defined as an involuntary contraction of the musculature surrounding the vaginal opening that interfered with penetration. More recently, the DSM-5 combined vaginismus and dyspareunia into a broader diagnosis known as Genito-Pelvic Pain/Penetration Disorder (GPPPD), citing overlap between the conditions. Yet many clinicians and sexual medicine specialists (including yours truly) continue to argue that vaginismus deserves recognition as a distinct process because of the profound muscular and reflexive components involved.

Regardless, in practical terms vaginismus can be understood as the body learning to resist penetration. The pelvic floor muscles surrounding the vaginal entrance contract reflexively in response to, or anticipation of, pain. Importantly, this contraction is not voluntary. Patients are not consciously “choosing” to tighten. Rather, the nervous system interprets penetration as threatening and initiates a protective response designed to prevent injury.

For many patients, this distinction can be profoundly validating. They have often spent years believing their body is betraying them or that they are somehow “failing” at intimacy. In reality, the body is doing exactly what it has been trained to do: protect itself from perceived danger. The tragedy of vaginismus is not that the body is malfunctioning, but that it has learned protection too well.

Subscribe now

How the Body Learns Fear

The exact origins of vaginismus are variable and often multifactorial. In some patients, the condition develops after painful penetration, traumatic gynecologic experiences, childbirth injury, or sexual trauma. In others, penetration may never have occurred successfully in the first place. These individuals often describe longstanding fear, shame, anxiety, or catastrophic beliefs surrounding penetration itself.

As expected, the nervous system plays a central role in this process. Pain, or even the anticipation of pain, activates protective muscular contraction around the vaginal entrance. If penetration continues despite this guarding, the nervous system begins reinforcing the association between penetration and danger. Over time, the response becomes increasingly automatic through a process known as neuroplasticity. Eventually, the pelvic floor may contract before penetration even occurs, simply in response to anticipation alone.

Cultural and psychological conditioning may also contribute significantly. Many patients with primary vaginismus report growing up with messaging that framed sex as frightening, shameful, dangerous, sinful, or inevitably painful. Phrases such as “sex always hurts,” “good girls don’t do that,” or “they told me that something is going to tear” may seem emotionally distant in adulthood, yet the nervous system often retains these associations remarkably well.

Importantly, vaginismus should never be reduced to “just anxiety.” Remember, anxiety is not separate from physiology - it changes physiology. Anticipatory fear alters breathing, increases sympathetic activation, reduces lubrication, increases muscle tension, and heightens vigilance toward pain. Blood rushes to the core, vital organs, and out of the genitalia. In this sense, the psychologic and physical aspects of vaginismus are not competing explanations, but interconnected components of the same protective system.

How Does Vaginismus Present Clinically

Patients with vaginismus most commonly present describing difficulty or inability to tolerate penetration. For some, intercourse is impossible altogether. Others may tolerate partial penetration accompanied by severe pain, panic, or muscular tightening. Tampon insertion, pelvic examinations, finger penetration, or even the anticipation of these experiences may provoke distress.

Clinically, the severity of vaginismus exists along a spectrum. Some patients demonstrate mild guarding that relaxes with reassurance and gradual examination. Others exhibit severe reflexive spasm accompanied by withdrawal behaviors, leg-locking, shaking, crying, or autonomic symptoms such as sweating, nausea, and palpitations. The Lamont-Pacik grading system attempts to classify these responses objectively based on the patient’s physical reaction during examination.

One of the most heartbreaking aspects of vaginismus is the emotional burden patients often carry privately. Many fear disappointing a partner, being abandoned, or being perceived as dysfunctional, while others begin avoiding relationships altogether because intimacy feels impossible to navigate. The shame associated with the condition can become so profound that some patients avoid medical care entirely for years, terrified of pelvic examination itself.

Partners, meanwhile, frequently misunderstand what they are witnessing. Because vaginismus is invisible externally, some assume the patient simply needs to “relax more” or “push through it.” In reality, the pelvic floor contraction occurring during vaginismus can be remarkably powerful and entirely involuntary. Understanding this changes the conversation from one of performance or willingness to one of nervous system protection and physiologic reflex.

How Do We Evaluate a Patient with Vaginismus?

Evaluation of vaginismus begins long before physical examination. The clinical environment itself matters enormously, as patients with severe penetration anxiety are often hypervigilant, scanning for signs of discomfort, dismissal, or loss of control. A rushed or forceful encounter may reinforce the very protective responses the clinician is attempting to understand.

As expected, a detailed history is essential, and questions should explore prior painful experiences, cultural messaging surrounding sex and relationship concerns, not to mention prior gynecologic trauma, or the patient’s specific fears regarding penetration. Distinguishing between primary and secondary vaginismus is also important, as patients who previously tolerated penetration often have a clearer precipitating event.

When examination is attempted, observation often becomes as informative as the exam itself. Some patients visibly tense before contact even occurs. Others withdraw, elevate their hips, adduct their thighs, or display involuntary pelvic floor contraction with minimal provocation. Importantly, these responses are not theatrical or exaggerated. Instead, they are objective manifestations of the central nervous system attempting to maintain safety.

Importantly…most importantly…evaluation should always proceed collaboratively. Patients must feel they can stop the examination at any point without disappointing the clinician. In some cases, a complete examination may not even be possible during the initial visit. In my opinion, allowing the patient to maintain control often reduces guarding substantially, because the nervous system no longer feels trapped or overpowered.

So, How Do We Treat It?

Treatment of vaginismus is fundamentally about retraining the nervous system. The goal is not simply forcing penetration to occur, but teaching the body that penetration no longer represents danger. This distinction matters enormously because attempts to “push through” vaginismus often worsen the condition by reinforcing fear and protective guarding.

Once vaginismus is diagnosed many patients find that pelvic floor physical therapy to be one of the most effective treatments available. Through gradual desensitization, muscular retraining, breathing techniques, and relaxation work, patients learn to interrupt reflexive guarding patterns and regain voluntary control of the pelvic floor. Vaginal dilators or trainers may also be incorporated progressively, allowing the nervous system to experience penetration in a controlled and non-threatening manner.

Psychotherapy and sexual counseling are equally important for many patients, particularly when fear, shame, trauma, or catastrophic anticipation are prominent features. Again, this does not imply the condition is “all in their head.” Rather, chronic pain and fear inevitably shape nervous system processing, and addressing those patterns directly may significantly improve outcomes. For these patients, referral to a therapist trained in trauma-reduction methods, such as EMDR or ART can be very beneficial.

More recently, chemodenervation with onabotulinumtoxinA (Botox) has emerged as a useful treatment option in selected patients with severe muscular spasm. By temporarily paralyzing hypercontracted pelvic floor muscles, Botox may interrupt long-standing guarding cycles and facilitate physical therapy and desensitization work. Increasingly, the best outcomes appear to arise from multimodal treatment strategies that combine physiotherapy, counseling, gradual exposure, and, when appropriate, procedural intervention.

In many ways, this reflects a broader principle within sexual medicine itself: conditions rooted in protection and anticipation rarely improve through force. They improve through safety, repetition, validation, and restoration of control. That process takes time, but for many patients, it is also the first time their body begins to feel understandable again.

Ultimately, vaginismus is not a failure of intimacy, femininity, or desire. It is a learned protective response created by a nervous system attempting to preserve safety. Treatment therefore succeeds not by overpowering the body, but by convincing it that protection is no longer necessary. In many ways, healing vaginismus is less about forcing the body open and more about teaching it that it no longer needs to stay closed.

Part of my own clinical and academic focus has involved procedural approaches to vaginismus management, including the use of pelvic floor chemodenervation combined with progressive desensitization and rehabilitation strategies. Increasing evidence suggests that multimodal treatment models incorporating pelvic floor physical therapy, counseling, vaginal trainers, and targeted muscular relaxation may significantly improve outcomes in carefully selected patients. Importantly, however, no procedural intervention should be viewed as a “magic fix.” The goal is not simply reducing muscular spasm, but creating an opportunity for the nervous system to relearn penetration without threat or pain.

© 2026 Corey R. Babb, DO, FACOOG, IF, MSCP. All rights reserved

Share Dr. Corey Babb

In the first article, sexual pain was introduced as more than a localized symptom. Pain alters anticipation, muscle tension, arousal, and behavior, gradually reshaping the relationship between intimacy and safety. That framework is essential to understanding vulvodynia, one of the most common and misunderstood sexual pain disorders.

This article focuses specifically on vulvodynia: what it is, why it develops, how it presents clinically, and why many patients struggle for years before receiving meaningful treatment.

What Is Vulvodynia?

The term vulvodynia simply means “pain in the vulva,” though the reality of the condition is considerably more complicated than the definition itself suggests. Vulvodynia is considered an umbrella diagnosis, one used to describe chronic vulvar pain in the absence of an immediately identifiable cause. According to the International Society for the Study of Vulvovaginal Disorders (ISSVD), vulvodynia is defined as vulvar pain lasting longer than three months without a clearly discoverable etiology.

This distinction is important because vulvodynia is descriptive rather than explanatory. In many ways, the diagnosis functions similarly to the phrase “headache.” It tells the clinician where the pain occurs, but not necessarily why it exists. Some patients ultimately prove to have specific etiologies; others exhibit patterns of centralized pain amplification in which the nervous system itself appears hypersensitized.

Vulvodynia is also extraordinarily common. Estimates suggest that approximately 16% of women worldwide experience vulvodynia at some point, with many cases occurring between the ages of twenty and forty. Despite this prevalence, underdiagnosis remains rampant, in part because many patients never disclose their symptoms, and in part because many clinicians receive little formal training in sexual pain evaluation.

Patients frequently arrive in clinic after years of uncertainty. Many have been repeatedly treated for presumed infections despite negative testing while others have been told their examinations are “normal,” leaving them feeling confused or invalidated by the absence of visible pathology. The invisibility of the condition often becomes one of its cruelest features. Patients are in pain, yet repeatedly encounter environments that subtly imply the pain should not exist.

Why Vulvodynia Develops

One of the greatest frustrations surrounding vulvodynia is that its exact cause remains incompletely understood. Current theories generally fall into two broad categories: those focused on localized tissue injury and those focused on abnormal nervous system processing. Increasingly, however, it appears that many patients exist somewhere between these extremes, with both peripheral and centralized mechanisms contributing simultaneously.

At the tissue level, repeated inflammation or irritation may sensitize local nociceptors over time. Chronic yeast infections, friction-related injury, or hormonal deprivation are frequently discussed as potential initiating events, while in peri- and postmenopausal patients, declining estrogen levels may thin vulvar and vestibular tissue, making it more vulnerable to irritation and microtrauma. Likewise, certain hormonal contraceptives may alter vestibular tissue quality in susceptible individuals, leaving pain long after the medication is discontinued.

Yet tissue alone does not fully explain vulvodynia. Many patients appear to develop a broader state of regional hypersensitivity in which the nervous system amplifies sensory input disproportionately. These individuals may also report urinary urgency or bowel symptoms, pelvic floor dysfunction, or other chronic pain conditions. In such cases, the issue is no longer confined to the vulvar tissue itself, but involves altered pain processing at multiple levels of the nervous system.

Over time, repeated painful experiences reinforce the association between touch and danger. Anticipation develops. Guarding develops. Hypervigilance develops. Eventually, even light contact that would ordinarily be interpreted as neutral may begin triggering pain responses. At that stage, vulvodynia has evolved beyond a simple inflammatory process and into a learned neurologic state shaped by neuroplasticity and reinforcement.

How Vulvodynia Presents Clinically

One of the defining characteristics of vulvodynia is variability. Some patients present with highly localized burning pain that occurs only during penetration, while others describe generalized discomfort present throughout the day regardless of activity. Pain may be provoked, spontaneous, or mixed. Some patients can identify a clear beginning to their symptoms, while others struggle to pinpoint when discomfort gradually became chronic.

The language patients use often provides important diagnostic clues. Burning, stinging, “electric,” or knife-like sensations frequently suggest neuropathic involvement, whereas dull or achy discomfort may point toward vascular or musculoskeletal contributors. Patients with vestibulodynia may report severe pain specifically at the vaginal opening during penetration, tampon insertion, or even prolonged sitting. Others may describe clitoral hypersensitivity severe enough that clothing itself becomes irritating.

Emotionally, vulvodynia can become profoundly destabilizing. Chronic genital pain occupies an intensely private and psychologically vulnerable space. Patients often fear intimacy, as worsening symptoms can lead to relationship strain, and even permanent loss of sexual function. Some report depression or anxiety as their chief complaint during medical visits, only later revealing that the source of distress is persistent vulvar pain.

Importantly, vulvodynia rarely exists in isolation from the broader sexual response cycle. As I’ve discussed before, pain alters arousal, lubrication, and muscular tension simultaneously. Patients may begin avoiding intimacy not because desire has disappeared, but because the nervous system has learned that intimacy predicts discomfort, and over time, this distinction becomes increasingly difficult for patients themselves to recognize, further complicating both diagnosis and treatment.

Evaluating the Patient With Vulvodynia

Evaluation of vulvodynia requires patience, structure, and precision. Because many patients have previously experienced dismissal or minimization, the clinical encounter itself can become therapeutic. Validation matters enormously. Simply hearing that the pain is real and deserving of investigation may represent the first meaningful intervention a patient has received in years.

A thorough sexual medicine examination is essential. The clinician should map the location, quality, and provocation pattern of pain carefully. For this, the Q-tip test remains one of the most useful tools for identifying focal vestibular tenderness, allowing the examiner to reproduce and localize pain systematically. Vulvoscopy may also be helpful, particularly when evaluating subtle erythema, dermatologic changes, or glandular abnormalities.

Attention should also be directed toward potential secondary contributors. Infection must be excluded when symptoms suggest vaginitis or other microbiologic pathology. Hormonal status should be considered, especially when vestibular tissue appears thin, erythematous, or fragile. Clitoral examination is equally important, as clitoral adhesions, keratin pearls, and even entrapped pubic hair may occasionally contribute to clitorodynia.

Perhaps most importantly, evaluation should extend beyond the vulva itself. Pelvic floor dysfunction commonly coexists with vulvodynia, either as a contributor to pain or as a secondary guarding response. Hypertonic pelvic floor musculature may dramatically amplify discomfort and perpetuate pain cycles. In many patients, successful treatment ultimately requires addressing both vulvar hypersensitivity and the muscular protective patterns that develop around it.

Treating Vulvodynia, and Why It Often Requires More Than One Therapy

There is no single universal treatment for vulvodynia because there is no single universal mechanism behind it. Effective treatment therefore tends to be multimodal, combining therapies aimed at tissue health, neural regulation, pelvic floor function, and emotional adaptation simultaneously. The goal is not simply suppressing symptoms, but reducing the nervous system’s expectation of pain.

For most patients, lifestyle modification is often an important starting point. Elimination of irritating soaps, detergents, restrictive clothing, or friction-provoking activities may significantly reduce symptom burden in some patients, and lubricants, topical lidocaine, and positional changes during intimacy may further improve comfort. These interventions are supportive rather than curative, but they help decrease repetitive nociceptive input that perpetuates sensitization.

Pelvic floor physical therapy remains one of the most valuable interventions available, particularly when muscular guarding or spasm is present. Likewise, cognitive behavioral therapy and sexual counseling may help patients address fear, catastrophization, and anticipatory anxiety surrounding intimacy. This is not because the pain is “psychological,” but because chronic pain inevitably affects emotional and neurologic processing simultaneously.

Yet perhaps the most important aspect of treatment is helping patients understand that pain with sex is neither imaginary nor inevitable. Vulvodynia is real. It is physiologic. And while treatment is often gradual and multifaceted, improvement is possible when the nervous system, tissue, and behavioral components of pain are addressed together.

© 2026 Corey R. Babb, DO, FACOOG, IF, MSCP. All rights reserved

Share Dr. Corey Babb

Pain with sex is extraordinarily common, yet it remains one of the least openly discussed concerns in medicine. Many patients endure symptoms silently for years, often assuming discomfort is simply part of the sexual experience, aging, childbirth, or partnership itself. Others seek care only after the pain has begun to affect relationships, emotional health, or their sense of identity.

This series will examine the mechanisms of sexual pain, the major conditions associated with it, and the treatment strategies used to restore comfort and function. More importantly, it will explore what persistent pain does to the brain and body over time, and why treating sexual pain requires more than simply eliminating a symptom.

Introduction and Why This Series Matters

Pain is one of the most universal human experiences. From childhood onward, the body continuously learns to identify and avoid harmful stimuli, using pain as a warning system to preserve safety and survival. Sexual pain is no exception. Yet despite how common painful intercourse is, it is frequently minimized, misunderstood, or treated as though it exists outside the scope of “real” pain. Patients are often told to relax, use more lubricant, drink wine, or simply “give it time,” despite the fact that pain with intimacy can become profoundly disruptive to emotional and relational health.

Part of the problem is cultural. Female discomfort is often normalized in ways that male pain is not (see this article for more on this topic). Menstrual cramps, postpartum healing, menopausal dryness, and painful intercourse are routinely framed as inconveniences to tolerate rather than physiologic problems deserving evaluation. Many patients therefore arrive in clinic already carrying years of reinforcement that discomfort is expected, unavoidable, or somehow reflective of personal inadequacy. By the time they seek care, the pain has often expanded beyond the bedroom itself.

Sexual pain also occupies a uniquely vulnerable space psychologically. Unlike pain isolated to a knee, shoulder, or back, sexual pain affects intimacy, partnership, identity, and self-perception simultaneously. Patients may fear disappointing a partner, losing a relationship, or being perceived as “broken.” Others begin avoiding intimacy entirely, not because desire is absent, but because the body has learned to associate sex with danger. Over time, this association becomes increasingly difficult to separate from sexuality itself.

This is why sexual pain deserves a dedicated discussion rather than a brief mention under the broader scope of female sexual dysfunction. Pain alters behavior. It changes the nervous system. It reshapes expectation and anticipation, and for many patients, the pain eventually becomes larger than the original cause that initiated it. Understanding that progression is essential, because treatment of sexual pain requires more than addressing tissue alone - it requires understanding the cycle that pain creates.

Why Do We Hurt?

At its most basic level, pain is a protective mechanism. Throughout the body, specialized sensory receptors known as nociceptors continuously monitor for potentially harmful stimuli. These stimuli may be mechanical, such as stretching or compression; chemical, such as inflammation or irritation; or thermal, such as excessive heat or cold. When the threshold for danger is exceeded, signals travel from peripheral nerves to the spinal cord and ultimately to the brain, where the sensation of pain is processed and interpreted.

The genitalia possess an exceptionally dense nerve supply, which is one reason sexual sensation can feel intensely pleasurable under appropriate conditions. However, this same anatomy also makes the region highly capable of generating pain. Friction against dry tissue, compression of inflamed structures, stretching of scarred tissue, or spasm of the pelvic floor musculature may all activate nociceptive pathways. Inadequate lubrication alone may lead to burning, tearing, or fissuring sensations during penetration. Likewise, deep penetration may reproduce pain that can be dull, achy, or sharp - all dependent on the underlying cause.

Importantly, the body responds reflexively to painful stimulation. Muscles tighten, breathing changes, and the nervous system shifts toward protection. These reactions are not conscious decisions, but automatic survival responses designed to minimize further injury. During sexual activity, this may manifest as involuntary tightening of the pelvic floor, withdrawal from touch, or difficulty maintaining arousal. Over time, the body may begin initiating these protective responses before penetration even occurs, simply in anticipation of discomfort.

This anticipatory response is one of the reasons sexual pain becomes so difficult to untangle. The nervous system does not simply remember pain, it learns from it. Once that learning occurs, the body may continue behaving as though danger is present even after the original injury or irritation has improved. In this sense, pain evolves from a symptom into a conditioned physiologic response, one capable of sustaining itself long after the initial trigger has faded.

What Pain Does to the Brain

Pain is not experienced solely at the level of tissue. It is ultimately constructed within the brain, where sensory input is filtered through memory, emotion, prior experience, and context. Signals arriving from peripheral nerves travel through the spinal cord and into regions such as the thalamus, limbic system, and cerebral cortex, where meaning is assigned to the sensation. Two individuals may therefore experience the same stimulus in dramatically different ways depending on their prior experiences and emotional state.

This becomes especially important in chronic sexual pain. The brain possesses a remarkable ability to adapt to repeated experiences, a process known as neuroplasticity. While this adaptability is often beneficial, it can become maladaptive in the setting of persistent pain. Repetitive painful intercourse reinforces the association between penetration and danger, gradually strengthening neural pathways that anticipate discomfort. Eventually, anxiety, guarding, and hypervigilance may occur before physical contact even begins.

The result is a type of feedback loop. Anticipation of pain increases sympathetic (our “fight or flight” mechanism) nervous system activation, which decreases genital blood flow and lubrication while simultaneously increasing muscular tension. Reduced arousal then increases friction and discomfort, reinforcing the original pain response. Each painful encounter strengthens the association further, making future intimacy progressively more difficult. At this stage, the nervous system is no longer merely responding to pain, it is actively helping maintain it.

Emotionally, this process can be devastating. Sexuality occupies a deeply personal space, and repeated pain often produces feelings of shame, frustration, guilt, or inadequacy. Patients may begin questioning their desirability, fearing relationship instability, or feeling disconnected from their own bodies. Some endure pain silently to preserve intimacy with a partner, while others avoid sexual activity entirely. In both scenarios, the emotional burden of pain often becomes inseparable from the physical sensation itself.

The Long-Term Effects of Sexual Pain

Persistent sexual pain rarely remains isolated to sexual activity alone. Over time, it often begins influencing posture, movement, mood, relationships, and overall quality of life. Patients with chronic pelvic pain frequently report urinary urgency, constipation, low back pain, hip discomfort, or difficulty tolerating prolonged sitting. These symptoms may initially appear unrelated, yet they often reflect the broader effects of chronic guarding and nervous system sensitization.

Relationship dynamics may also shift significantly. Partners may become hesitant to initiate intimacy out of fear of causing discomfort, while patients themselves may feel pressure to continue sexual activity despite pain. This dynamic frequently produces cycles of avoidance, resentment, guilt, or emotional withdrawal. Importantly, many patients report that the relational consequences of sexual pain are ultimately more distressing than the pain itself.

Furthermore, longstanding pain may also alter sexual identity. Patients who once viewed sexuality as pleasurable or connecting may begin associating it primarily with anxiety, obligation, or failure. Desire often diminishes secondarily, not because libido is intrinsically impaired, but because the brain has learned that intimacy predicts discomfort. This distinction matters greatly, as many patients incorrectly assume they have “lost desire” when the true issue is unresolved pain.

Unfortunately, these long-term effects are often compounded by invalidation. Many patients describe prior medical encounters in which their symptoms were minimized or dismissed altogether. Being told that pain is “normal,” “just stress,” or something to endure may intensify feelings of isolation and hopelessness. Validation therefore becomes a critical therapeutic intervention in its own right. Patients need to hear, clearly and directly, that pain with sex is not something they are expected to simply tolerate.

What Comes Next

One of the greatest misconceptions about sexual pain is that it represents a single condition. In reality, painful intercourse is a symptom with numerous possible causes, ranging from vulvar hypersensitivity and pelvic floor dysfunction to hormonal changes, neuropathic pain, musculoskeletal injury, and centralized pain amplification. Effective treatment therefore begins not with assumptions, but with careful evaluation and classification.

The next articles in this series will focus on several of the most common and clinically important causes of sexual pain. Vulvodynia will be examined first, including how chronic vulvar pain develops and why it is so frequently misunderstood. Subsequent discussions will explore vaginismus, pelvic floor dysfunction, and the treatment strategies used to restore comfort and intimacy.

Importantly, these conditions do not exist in isolation. Many patients exhibit overlapping features of multiple pain disorders simultaneously. A patient with vulvodynia may also develop pelvic floor spasm, just as a patient with vaginismus may eventually develop generalized pelvic pain due to chronic guarding. Understanding how these systems interact is essential, because successful treatment rarely involves addressing only one component of the problem.

Ultimately, the goal of this series is not simply to discuss pain, but to reframe how sexual pain is understood altogether. Pain with intimacy is not weakness, exaggeration, or failure. It is a physiologic process with neurologic, emotional, and relational consequences. And like any other pain condition, it deserves thoughtful evaluation, careful treatment, and compassion from the clinicians entrusted to manage it.

© 2026 Corey R. Babb, DO, FACOOG, IF, MSCP. All rights reserved

Share Dr. Corey Babb

In the preceding articles, arousal was defined, deconstructed into its component systems, examined through patterns of failure, and translated into a structured diagnostic approach. That progression was intentional. Without a clear understanding of mechanism, treatment becomes generalized, and outcomes become inconsistent.

This article focuses on restoration. Not the pursuit of arousal as an isolated endpoint, but the re-establishment of the conditions under which arousal can occur reliably and appropriately.

By the time patients seek care for arousal concerns, many have already tried to “fix” the problem. Hormones, supplements, lubricants, changes in routine, or sometimes all at once. Occasionally something helps…but often, it doesn’t. What’s missing, however, is not effort, but alignment, as arousal is not restored by trying more things. It is restored by targeting the right part of the system.

The most common mistake in the treatment of arousal disorders is not the selection of the wrong therapy, but the application of a therapy without a clear understanding about the disconnect of the underlying mechanism. When arousal is treated as a singular entity, interventions are often chosen based on familiarity, availability, or patient expectation rather than physiologic alignment. This leads to a pattern of partial response, transient benefit, or complete failure.

Arousal, as previously established, is not a single pathway but a coordinated system. Multiple systems - neurologic, vascular, hormonal, and psychologic must all function in concert. Restoration, therefore, does not involve “increasing arousal” in a general sense, but correcting the specific component of the system that is impaired. This requires precision, both in diagnosis and in therapeutic selection.

As discussed previously, this means that the same treatment may be highly effective in one patient and entirely ineffective in another. A patient with vascular insufficiency may respond well to therapies that enhance blood flow, while a patient with central inhibition may derive little benefit from those same interventions. Without a clear understanding of where the system is failing, these differences can be misinterpreted as variability in treatment efficacy rather than mismatch in application.

That said, let’s look at the different therapies in more detail.

Read more

This is the fourth article in a five-part series examining sexual arousal as a distinct physiologic process.

In the prior article, we looked at arousal through the lens of failure patterns, with an emphasis on how dysfunction presents in clinical practice. Those patterns -diminished response, discordance, and dysregulated activation - provide a necessary framework, but they do not, on their own, establish a diagnosis.

This article focuses on the next step: how those patterns are evaluated. The goal is not to create a checklist, but to develop a structured approach that allows the clinician to move from symptom description to mechanism-based diagnosis.

Diagnosis Begins with the Pattern

The diagnostic process for arousal disorders does not, maybe surprisingly, begin with testing, but instead with interpretation. Patient complaints, physical exam findings, and the patterns described previously are not endpoints, but are instead entry points into evaluation, and before any additional studies - lab work, imaging, etc., is considered, the clinician must first determine how the system as a whole appears to be failing. This initial step guides everything that follows.

A patient who presents with diminished arousal requires a different evaluation than one who presents with persistent or dysregulated activation. Similarly, a patient with discordant arousal necessitates a wider, less-focused assessment that includes both central and peripheral domains. Without these initial classifications, the diagnostic process risks becoming unfocused, with tests ordered in parallel rather than in sequence.

This approach stands in contrast to a more generalized models of care, in which evaluation may proceed along standardized pathways regardless of presentation. While such guideline-based models offer efficiency, they often do so at the expense of specificity, and in the context of arousal disorders, where multiple systems may be involved, this lack of precision can obscure the underlying mechanism.

History is 99% of the Diagnosis

A detailed clinical history remains the most valuable tool in the evaluation of arousal disorders. While patients may initially describe their symptoms in broad or ambiguous terms, careful questioning can often clarify the underlying pattern. The goal is not simply to document symptoms, but to understand their context, timing, and variability, as well as how they relate to the patient’s experience.

Key elements include the onset of symptoms, their progression over time, and any identifiable triggers or relieving factors. The relationship between desire and arousal should be explored explicitly, as patients may not distinguish between these domains without guidance. Additionally, questions regarding lubrication, sensation, and the consistency of response can help differentiate between vascular, neural, and central contributions.

Outside of symptoms, contextual factors provide equally important information. Medications, particularly those affecting neurotransmitters (SSRIs, anxiolytics, etc.,) may alter both central processing and peripheral response. Psychosocial factors, such as overall stress, relationship dynamics, and even prior experiences, may influence how stimuli are interpreted and whether arousal is permitted to occur. These elements do not exist separately from physiology, but interact with it in complex ways.

If you recall the case study from this article…

the history provided critical clues. The association with cycling, the presence of hip discomfort, and the relief with stimulation all pointed toward a peripheral or musculoskeletal contributor. Without obtaining a detailed history, these associations may have been overlooked, leading to a more generalized and less effective evaluation.

Physical Examination and Targeted Assessment

For the trained clinician, the physical examination serves as an extension of the history, providing objective data that can confirm or refine the working hypothesis. In the context of arousal disorders, the examination should be both focused and deliberate, with attention to genital, pelvic, and, when indicated, musculoskeletal structures.

Genital examination may reveal signs of hormonal deficiency, such as thinning of the vaginal epithelium, decreased elasticity, or reduced base-line lubrication. Clitoral phimosis, a condition in which the prepuce of the clitoris is aberrantly adhered to the glans of the clitoris itself, can be a major source not only of decreased arousal response, but also pain with genital palpation. Sensory testing, while often underutilized, can provide insight into peripheral nerve function, particularly in patients reporting diminished or altered sensation. These findings, when present, help localize dysfunction to specific components of the system.

A pelvic floor assessment is equally important. Hypertonicity of the pubococcygeus, iliococcygeus, and obturator interni structures may contribute to pain and altered sensory input, while at the same time prohibiting proper vascular engorgement. Hypotonicity, conversely, may affect pelvic organ support, leading to overall decreased sensation. In patients with persistent or dysregulated arousal, evaluation of surrounding musculoskeletal structures, including the hips and lower back, may reveal contributing factors such as nerve irritation or joint dysfunction.

The Role of Testing and Imaging

Laboratory testing and imaging play a supportive role in the diagnosis of arousal disorders, but they are not primary tools. Their utility depends on the clinical context and should be guided by the pattern identified during history and examination. Broad, non-targeted testing rarely yields meaningful insight and may contribute to unnecessary anxiety for the patient, not to mention increase cost or healthcare burden.

Hormonal evaluation may be appropriate in patients with suspected endocrine contributions, particularly those with symptoms consistent with menopause or androgen deficiency. However, as previously discussed, hormonal factors are permissive rather than primary drivers of arousal. Abnormalities, when present, must be interpreted within the broader clinical picture.

Imaging may be indicated in cases where structural or neurologic contributors are suspected. Pelvic MRI, for example, may identify masses, nerve entrapment, or other anatomic abnormalities, while sacral MRI (which is very different from a pelvic MRI!) may demonstrate cysts along the pudendal nerve (the main sensory nerve of the genitalia) roots, which can contribute to both decreased arousal as well as persistent arousal symptoms. In patients with suspected musculoskeletal involvement, imaging of the hips or spine may reveal pathology that likewise contributes to symptoms. These studies, however, are most useful when directed by a clear clinical question.

From Evaluation to Diagnosis

The diagnosis of arousal disorders is not the result of a single step, but the culmination of a structured process. It begins with pattern recognition, is refined through history and examination, and is supported, when necessary, by targeted testing. Each step builds upon the previous one, narrowing the differential and clarifying the underlying mechanism.

This approach allows for a more precise and individualized diagnosis. Rather than assigning a broad label, the clinician is able to identify the specific domain or domains contributing to dysfunction. This, in turn, informs treatment, as interventions can be directed toward the relevant component of the system rather than applied indiscriminately.

It also highlights the limitations of relying solely on diagnostic categories. While labels may be useful for communication, they do not capture the complexity of the underlying physiology. Two patients with the same diagnosis may require entirely different approaches based on the specific nature of their dysfunction.

In the final article of this series, the focus will shift to treatment. Having established how arousal fails and how those failures are evaluated, the next step is to examine how the system can be restored. It is at this stage that the framework developed thus far becomes fully actionable, guiding the selection of interventions that are aligned with mechanism rather than assumption.

© 2026 Corey R. Babb, DO, FACOOG, IF, MSCP. All rights reserved

Share

In the prior article, we discussed arousal as an integrated system involving neural signaling, vascular response, hormonal changes, and sensory processing. That framework is essential, but it remains incomplete without an understanding of how that system fails in practice.

This article focuses on those failures. Rather than approaching arousal disorders as isolated diagnoses, the goal is to examine the patterns in which the system breaks down, and how those patterns can be recognized clinically.

From Mechanism to Failure

Understanding the physiology of arousal provides a necessary foundation for the sexual medicine clinician, but it does not, on its own, translate directly into diagnosis. Unfortunately, patients do not present with descriptions of neurotransmitters or vascular resistance, instead they present with experiences - changes in sensation, alterations in response, or disruptions in sexual function that are often difficult to describe with precision. The task of the sexual medicine clinician, therefore, is to translate those experiences back into roadmap showing where the dysfunction occurred.

In most cases, this translation is best accomplished through a type of pattern recognition. Rather than attempting to assign a diagnosis at the outset, it is often more useful to first identify how the system appears to be failing, i.e., is the issue one of absent response, diminished response, inconsistent response, or inappropriate activation? Each of these patterns reflects a different type of system failure.

Traditional diagnostic categories in sexual medicine, such as Female Sexual Interest and Arousal Disorder (FSIAD), which, while useful in certain contexts, can obscure this diagnostic process. By grouping diverse presentations under a single label, they can create the impression that conditions share a common mechanism. In reality, two patients with the same diagnosis may have entirely different underlying pathophysiology. As such, it is imperative to understand where, and how, the issues are arising.

Read more

Julia was a 56-year-old who presented to the clinic with a complaint that was both specific, and yet, difficult for her to articulate. She described a persistent sensation of fullness in her external genitalia, one that had been present for approximately one year but had become more pronounced over the past month. She was otherwise active, noting that she cycled regularly and practiced Pilates on a near-daily basis. While she had initially attributed the sensation to physical activity, the persistence and progression of symptoms had ultimately led her to seek evaluation.

As time passed, it became clear that her symptoms were not simply uncomfortable, but distressing. She reported that the sensation was intrusive enough to affect her daily life, becoming severe enough that at times, she did not want to leave her house. After some hesitation, she added that the sensation could be temporarily relieved with self-stimulation, though she expressed discomfort and reluctance in relying on this as a “coping mechanism,” as she called it.

Her physical examination was largely unremarkable. There were no visible vulvar lesions, no skin changes, and no obvious signs of infection or inflammation. However, she did report discomfort in the hip when positioning for an internal exam.

At this point, the clinical picture began to shift. What initially presented as a vague genital discomfort evolved into a pattern more consistent with a disorder of arousal, specifically one that was occurring outside of sexual activity and was experienced as unwanted and distressing. The association with physical activity, the presence of hip discomfort, and the relief with stimulation all suggested that this was not necessarily a primary genital issue, but rather a problem arising from a broader neurovascular or musculoskeletal source.

Cases like Julia’s illustrate an important point. Not all arousal-related complaints presented simply as a lack of response. Some presented as excess, misdirected, or poorly regulated signaling. Without a clear framework for understanding arousal as a systemic response, these presentations could be misinterpreted, minimized, or attributed to the wrong source entirely.

In this series, we will discuss arousal in all of its facets - the how, the why, what happens when it does not work the way it is supposed to, and what can be done to improve it.

Read more

There’s an assumption in how medicine typically works, a rhythm, if you will. A patient presents with a symptom, the clinician evaluates, a diagnosis is made, and that diagnosis points toward a defined therapy. This is the clinical path that most patients expect, and that most clinicians are trained to provide. In this case, a diagnosis of hypertension leads to antihypertensives, hypothyroidism leads to replacement. The pathway is not necessarily simple, but it is structured, and over time it becomes predictable.

Patients often bring that same expectation into the sexual medicine clinic…but sexual desire does not follow that model.

As we discussed in the last article, the diagnosis of sexual desire disorders can present in very different ways. One patient may describe a complete absence of spontaneous desire, but intact enjoyment once engaged. Another describes a loss of both initiation and engagement. A third presents in the setting of medication use, relationship strain, or chronic fatigue, where the pattern is influenced by factors outside of desire itself.

In this context, a diagnosis does not function as a prescription. It functions, instead, as a starting point, and the clinician still has to determine which aspect of the system has changed and how that change is being expressed. Without that step, treatments can become applied to the label rather than the mechanism, and the results are often inconsistent.

Read more

She came into the office for “hormonal concerns.”

The intake form was filled out in the way these often are: fatigue, difficulty sleeping, weight changes, mood shifts. Nothing that immediately pointed in a single direction. The conversation followed the same pattern. A series of symptoms, each reasonable on its own, but not yet connected.

It wasn’t until later in the visit that she paused, almost as an afterthought.

“And… I just don’t want to have sex. At all.”

That was the first time the problem became clear.

Not because the symptom was new, but because it had finally been named in a way that could be examined. Up to that point, the visit could have moved in several directions - do we look at weight gain and insulin resistance, focus on nighttime symptoms, or the vaguest symptom, fatigue.

Even then, the evaluation did not begin with an answer. It began with a clarification.

What does “I just don’t want to have sex” actually mean?

For some patients, it reflects an absence of spontaneous desire. For others, it describes a change in initiation, or a difference in how sexual activity is experienced once it begins. Occasionally, it signals something else entirely, a response to discomfort, or to stress, or even to a shift in the relationship that has not yet been articulated.

The sentence sounds definitive, but in practice, it rarely is.

The rest of the visit, and how we evaluate these patients, depends on understanding what is contained within that phrase.

Read more

The Hormone Assumption

When sexual desire changes, hormones are often the first explanation patients reach for.

“I think my testosterone is low.”
“It must be my estrogen.”
“Can we check my levels?”

The reasoning feels intuitive. Hormones are powerful biological signals, and sexual desire is, at least in part, a biological experience. It seems natural, therefore, to assume that if something has changed, there must be a measurable shift underlying it…something that can be captured in a lab value, identified, and corrected.

Medicine has historically reinforced this way of thinking. Long before modern endocrinology existed, physicians attempted to isolate and manipulate gonadal extracts in an effort to influence behavior, guided by the belief that sexual function could be traced back to a definable physiologic source (this is a fascinating piece of medical history, that if you’re interested, I definitely recommend looking into. Start with Arnold Berthold!). That instinct has persisted into modern practice, where laboratory testing often becomes the first step in evaluating changes in libido.

And to some extent, that instinct is justified. Hormones do play a meaningful role in sexual desire…but not as much as you might think. They influence brain signaling, tissue function, energy levels, and mood, all of which contribute to the experience of sexuality.

But the relationship is not as direct as it appears.

Hormones do not act in isolation, nor do they operate in a linear, cause-and-effect fashion. A change in level does not reliably produce a predictable change in desire, and similar hormone profiles can be associated with very different lived experiences. What feels like a simple biological explanation quickly becomes more complex when examined closely.

The problem, then, is not that hormones are irrelevant. It is that they are often asked to explain far more than they are capable of explaining on their own.

Read more

Understanding those mechanisms is important because it reframes a common assumption. When people talk about sexual problems, the phrase that most often appears is low libido. In everyday conversation it seems straightforward, almost diagnostic. In clinical practice, however, that phrase rarely tells us enough to understand what is actually happening.

Patients usually describe their experience in simple terms. They may say that they “just don’t think about sex anymore,” or that their interest has faded over time. Sometimes the change feels sudden, sometimes gradual, but the underlying concern is often the same: something about their relationship with sexual desire no longer feels the way it once did. From a medical standpoint, however, low libido is not a true diagnosis, it is a symptom. Sexual desire is shaped by a wide range of biological, psychological, and relational factors, and when it changes the underlying cause may differ dramatically from one person to another.

For that reason, sexual medicine providers do not simply treat “low desire.” Instead, they look for patterns that suggest specific types of desire disorders.

Three clinical patterns appear most frequently when evaluating patients who are distressed by changes in sexual desire: Hypoactive Sexual Desire Disorder, Sexual Aversion Disorder, and Compulsive Sexual Behavior.

Each reflects a different relationship between desire, distress, and behavior, and understanding those distinctions is the first step toward meaningful treatment.

Read more

The Question Behind “Low Libido”

In the sexual medicine clinic, concerns about sexual desire are extraordinarily common. In my previous essay, I explored some of the misconceptions that shape how people think about libido.

Dr. Corey Babb

The Myth of “Low Libido”

The scene appears frequently in movies and television…

Read more

3 months ago · 1 like · Dr. Corey Babb

In the clinic, patients rarely arrive using technical language. Instead, they say things like, “I think my libido is gone,” or “I just don’t feel interested anymore.” Beneath those words is usually a deeper worry that something fundamental has changed…perhaps about their body, their relationship, or even their sense of sexual self.

The prevalence of this concern is striking. Sexual dysfunction affects roughly 40% of women overall, and among those seeking care, low desire is one of the most commonly reported concerns. At first glance the problem seems binary: desire used to be present, and now it is not. They used to want sex, and now they don’t.

But the clinical reality is rarely that simple. In many cases, what patients describe as low desire is not a primary loss of libido at all. Pain during intercourse, hormonal transitions, medication effects, sleep disruption, or relationship tension (and more) can all alter the experience of sexuality, and when sex becomes uncomfortable, frustrating, or emotionally complicated, desire often diminishes as a secondary effect.

In those situations, the loss of desire is not the central problem. It is a downstream consequence of something else that has changed in the sexual experience. For sexual medicine providers, the more important question is therefore not always why desire disappeared, but what changed in the system that normally allows desire to emerge.

To understand that shift, it helps to look at three things: how desire differs from arousal, how the brain’s reward system generates sexual motivation, and how biology, psychology, and relationships interact to shape libido.

Read more